CLINICAL_TRIALS
trial_result
· 2011-11-02
Clinical Trial Update: Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults [Phase 2]
Summary
Phase 2 study evaluating safety and immunogenicity of Sanofi Pasteur's ChimeriVax West Nile Vaccine in healthy adults, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: West Nile Fever | Phase 2 | Status: COMPLETED | Results posted: 2011-11-02